BioVie, Inc. (BIVI)
2.16
-0.03
(-1.37%)
USD |
NASDAQ |
Aug 28, 16:00
2.17
+0.01
(+0.46%)
After-Hours: 20:00
BioVie Debt to Equity Ratio : 0.0268 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0268 |
| March 31, 2026 | 0.0189 |
| December 31, 2025 | 0.0163 |
| September 30, 2025 | 0.0134 |
| June 30, 2025 | 0.0184 |
| March 31, 2025 | 0.0168 |
| December 31, 2024 | 0.016 |
| September 30, 2024 | 0.2642 |
| June 30, 2024 | 0.3941 |
| March 31, 2024 | 0.4447 |
| December 31, 2023 | 1.370 |
| September 30, 2023 | 1.641 |
| June 30, 2023 | 0.94 |
| March 31, 2023 | 0.6398 |
| December 31, 2022 | 0.5128 |
| September 30, 2022 | 2.154 |
| June 30, 2022 | 3.341 |
| March 31, 2022 | 1.180 |
| December 31, 2021 | 0.6916 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.0055 |
| December 31, 2020 | 0.0048 |
| September 30, 2020 | 0.0043 |
| June 30, 2020 | -0.0401 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1964 |
| December 31, 2019 | -0.0252 |
| September 30, 2019 | -0.0002 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 7.427 |
| March 31, 2018 | 1.082 |
| December 31, 2017 | 0.728 |
| September 30, 2017 | 0.0092 |
| June 30, 2017 | 0.0302 |
| March 31, 2017 | 0.0067 |
| December 31, 2016 | 0.0154 |
| September 30, 2016 | 0.0114 |
| June 30, 2016 | 0.0052 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 14.25M |
| Total Liabilities (Quarterly) | 3.980M |
| Shareholders Equity (Quarterly) | 10.27M |
| Current Ratio | 3.594 |
| Net Debt Paydown Yield | 0.12% |